Recent articles
Filters
Article types
Publication dates
Issues
Expanding the results
Sections

151 - 159 of 159 Items

Review paper2022, feb 11

The dose no longer plays a paramount role in radiotherapy (oncology), but time apparently does

Bogusław Maciejewski, Krzysztof Składowski

Vol 72, No 2 (2022)

Review paper

Nowotwory. Journal of Oncology 2022;72(2):80-85.
Research paper (original)2022, feb 10

Sexual Health in breast cancer patients in Poland

Joanna Kufel-Grabowska, Milena Lachowicz, Mikołaj Bartoszkiewicz, Rodryg Ramlau, Daniel Maliszewski, Krzysztof Łukaszuk

Vol 72, No 2 (2022)

Research paper (original)

Nowotwory. Journal of Oncology 2022;72(2):74-79.
Review paper2022, feb 9

Phacomatoses, genetic testing for personalisation of clinical management (part 2)

Anna Kofla-Dłubacz, Andrzej Stawarski, Tomasz Pytrus, Justyna Gil

Vol 72, No 1 (2022)

Review paper

Nowotwory. Journal of Oncology 2022;72(1):58-64.
Review paper2022, feb 9
Guidelines / Expert consensus2022, feb 9

Consensus on methods of development of clinical practice guidelines in oncology under the auspices of Maria Sklodowska-Curie National Research Institute of Oncology and the Agency for Health Technology Assessment and Tariff System

Jan Walewski, Dominik Dziurda, Mariusz Bidziński, Barbara Bobek-Bilewicz, Marek Dedecjus, Iwona Hus, Beata Jagielska, Jacek Jassem, Andrzej Kawecki, Dariusz Kowalski, Magdalena Krasztel, Maciej Krzakowski, Tomasz Kubiatowski, Piotr Potemski, Radosław Mądry, Piotr Rutkowski, Anna Rychert, Janusz Ryś, Krzysztof Składowski, Rafał Tarnawski, Hanna Tchórzewska-Korba, Andrzej Tysarowski, Piotr J. Wysocki, Roman Topór-Mądry

Vol 72, No 1 (2022)

Guidelines / Expert consensus

Nowotwory. Journal of Oncology 2022;72(1):44-50.
Review paper2022, feb 9

The Poly(ADP-ribose) polymerase inhibitors in pancreatic cancer

Katarzyna Zubik, Julia Talaśka, Dawid Sigorski, Sergiusz Nawrocki

Vol 72, No 1 (2022)

Review paper

Nowotwory. Journal of Oncology 2022;72(1):34-43.
Review paper2022, feb 9

Off-label use of medicinal products in oncology: exercising due diligence or experimental activity?

Justyna Estera Król-Całkowska, Janusz Jaroszyński

Vol 72, No 1 (2022)

Review paper

Nowotwory. Journal of Oncology 2022;72(1):26-33.
Research paper (original)2022, feb 9

Secondary prevention and treatment of cervical cancer – an update from Poland

Patryk Poniewierza, Marcin Śniadecki, Michał Brzeziński, Dagmara Klasa-Mazurkiewicz, Grzegorz Panek

Vol 72, No 1 (2022)

Research paper (original)

Nowotwory. Journal of Oncology 2022;72(1):20-25.
Letter to the Editor2022, jan 24

Does the culture of science publishing need to change from the status quo principle of “trust me”?

Jaime A. Teixeira da Silva

Vol 72, No 2 (2022)

Letter to the Editor

Nowotwory. Journal of Oncology 2022;72(2):137-138.